Biopharma Dealmakers’ July edition lays out Biovian’s One-Stop-Shop CDMO concept

• 9.7.2020

Biovian’s One-Stop-Shop service concept is presented in Biopharma Dealmakers’ July edition: “Biovian: a true One-Stop-Shop CDMO with gene therapy capacity and Nordic ethos” The article describes how the Nordic Biovian delivers a comprehensive and reliable …

Biovian signs an agreement about early-stage development and manufacturing of a COVID-19 vaccine candidate.

• 15.6.2020

Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine.

Biovian in Biopharma Dealmakers’ latest edition

• 1.6.2020

Biovian, a Nordic Bio-CDMO is presented in the Biopharma Dealmakers’ June edition that focuses on next-generation therapeutics. The article describes Biovian’s concept of a true One-Stop-Shop that covers both the supply chain and the value chain.

Biovian is looking forward to discussing joint efforts against COVID-19.

• 30.4.2020

Biovian is looking forward to discussing joint efforts against COVID-19.

Biovian – in the freshly released European Biotechnology Spring issue 2020

• 16.4.2020

European Biotechnology has published their spring issue with a bioprocessing special. Biovian is one of the CDMOs presented with an editorial article.

Biovian’s new facility for Viral Vector GMP manufacturing is completed

• 31.3.2020

Biovian has expanded its GMP Viral Vector contract development and manufacturing facilities.